People | August 29, 2023
Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Marks the World Head & Neck Cancer Day at the OCTF Conference
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
Company to open new headquarters in 2024
Subscribe To Our Newsletter & Stay Updated
